Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 9633-9652
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9633
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9633
Assay | Manufacturer | Method | LOD, IU/mL(dynamic range, IU/mL) |
Qualitative | |||
Amplicor HCV v2.0 | Roche molecular system | RT-PCR (manual) | 50 |
Cobas Amplicor HCV v2.0 | Roche molecular system | Semi-automated RT-PCR | 50 |
Ampliscreen1 | Roche molecular system | Semi-automated RT-PCR | < 50 |
Versant HCV RNA | Siemens healthcare diagnostics | Semi-automated TMA | 10 |
Procleix HIV-1/HCV1 | Chiron corporation | TMA (manual) | < 50 |
Quantitative | |||
Amplicor HCV Monitor | Roche molecular system | RT-PCR (manual) | N/A (600-700000) |
Cobas Amplicor HCV Monitor v2.0 | Roche molecular system | Semi-automated RT-PCR | 600 (600-500000) |
Versant HCV 1.0 Assay K-PCR | Siemens healthcare diagnostics | Semi-automated RT-PCR | 15 (15-100000000) |
Abbott RealTime HCV Assay | Abbott diagnostics | Semi-automated RT-PCR | 12 (12-100000000) |
LCx HCV RNA Quantitative Assay | Abbott diagnostics | Semi-automated RT-PCR | 25 (25-2630000) |
Cobas Ampliprep/Taqman | Roche molecular system | Semi-automated RT-PCR | 15 (15-100000000) |
- Citation: Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol 2014; 20(29): 9633-9652
- URL: https://www.wjgnet.com/1007-9327/full/v20/i29/9633.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.9633